1. Home
  2. PLRX vs RYI Comparison

PLRX vs RYI Comparison

Compare PLRX & RYI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PLRX
  • RYI
  • Stock Information
  • Founded
  • PLRX 2015
  • RYI 1842
  • Country
  • PLRX United States
  • RYI United States
  • Employees
  • PLRX N/A
  • RYI N/A
  • Industry
  • PLRX Biotechnology: Pharmaceutical Preparations
  • RYI Metal Fabrications
  • Sector
  • PLRX Health Care
  • RYI Industrials
  • Exchange
  • PLRX Nasdaq
  • RYI Nasdaq
  • Market Cap
  • PLRX 682.2M
  • RYI 661.1M
  • IPO Year
  • PLRX 2020
  • RYI N/A
  • Fundamental
  • Price
  • PLRX $11.14
  • RYI $20.53
  • Analyst Decision
  • PLRX Strong Buy
  • RYI Hold
  • Analyst Count
  • PLRX 7
  • RYI 1
  • Target Price
  • PLRX $40.50
  • RYI $28.00
  • AVG Volume (30 Days)
  • PLRX 435.8K
  • RYI 203.5K
  • Earning Date
  • PLRX 02-26-2025
  • RYI 02-20-2025
  • Dividend Yield
  • PLRX N/A
  • RYI 3.69%
  • EPS Growth
  • PLRX N/A
  • RYI N/A
  • EPS
  • PLRX N/A
  • RYI 0.64
  • Revenue
  • PLRX N/A
  • RYI $4,703,700,000.00
  • Revenue This Year
  • PLRX N/A
  • RYI N/A
  • Revenue Next Year
  • PLRX N/A
  • RYI $1.76
  • P/E Ratio
  • PLRX N/A
  • RYI $32.01
  • Revenue Growth
  • PLRX N/A
  • RYI N/A
  • 52 Week Low
  • PLRX $10.22
  • RYI $17.18
  • 52 Week High
  • PLRX $18.92
  • RYI $36.15
  • Technical
  • Relative Strength Index (RSI)
  • PLRX 37.87
  • RYI 52.33
  • Support Level
  • PLRX $10.94
  • RYI $20.04
  • Resistance Level
  • PLRX $12.70
  • RYI $21.15
  • Average True Range (ATR)
  • PLRX 0.72
  • RYI 0.74
  • MACD
  • PLRX -0.16
  • RYI 0.40
  • Stochastic Oscillator
  • PLRX 13.76
  • RYI 84.37

About PLRX Pliant Therapeutics Inc.

Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel therapies for the treatment of fibrosis and related diseases. Its primary product candidate is bexotegrast (PLN-74809), an oral, small molecule, that the company is developing for the treatment of idiopathic pulmonary fibrosis, or IPF, and primary sclerosing cholangitis.

About RYI Ryerson Holding Corporation

Ryerson Holding Corp provides a metals service center, and value-added processor and is a distributor of industrial metals with operations in the United States, Canada, and Mexico. In addition to its North American operations, it conducts processing and distribution operations in China. Its customers range from local, independently owned fabricators and machine shops to large, international original equipment manufacturers. It carries a full line of products in stainless steel, aluminum, carbon steel, and alloy steels and a limited line of nickel and red metals in various shapes and forms. The company generates substantially all of its revenue from sales of metal products. Geographically, the majority is from the United States.

Share on Social Networks: